Evidence map›Paper›PMID 30320292›Full record

ArticleACS omega2018

Exploring the Inhibitory and Antioxidant Effects of Fullerene and Fullerenol on Ribonuclease A.

Pritam Roy, Sudipta Bag, Debanjana Chakraborty, Swagata Dasgupta

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Effect of Fullerenol CMolecules (Basel, Switzerland) · 2025
    Article
  4. Distinctive Effects of Fullerene CAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Structure and Vibrational Spectroscopy of CMolecules (Basel, Switzerland) · 2023
    Article
  14. Review
  15. Polyhydroxylated Fullerene CJournal of inflammation research · 2023
    Article
  16. Novel CMolecules (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Antioxidant Potential of Aqueous Dispersions of Fullerenes CInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pritam RoyDepartment of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Sudipta BagDepartment of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Debanjana ChakrabortyDepartment of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Swagata DasguptaDepartment of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Indian Institute of Technology Kharagpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fullerene-protein interaction studies have been a key topic of investigation in recent times, but the lower water solubility of fullerene somewhat limits its application in the biological system. In this work, we have compared the activities of fullerene and its water-soluble hydrated form, that is fullerenol, on ribonuclease A (RNase A) under physiological conditions (pH 7.4). The interaction studies of fullerene and fullerenol with protein suggest that the binding depends on the hydrophobic interactions between the protein and the ligand. In addition, fullerene and fullerenol slow down the ribonucleolytic activity of RNase A through noncompetitive and mixed types of inhibition, respectively. This precisely gives the idea about the ligand-binding sites in RNase A, which has further been explored using docking studies. Both these nanoparticles show a reduction in dityrosine formation in RNase A caused due to oxidative stress and also prevent RNase A dimer formation to different extents depending on their concentration.

Identifiers

PMID30320292
PMCPMC6173555
OpenAlexW2893162280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.